Freeline Therapeutics Holdings plc - 35655L107
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q2 2022
· Q1 2022
Value (USD)
Total reported value ($000)
$6.16M
QoQ value delta ($000)
+$635K
(+11.49%)
Implied price effect (QoQ)
-21.44%
Shares
Total shares
7,088,298
QoQ shares delta
+2,093,867
(+41.92%)
Total shares held by funds (by quarter)
Top holders (Q2 2022)
Top 25 only
Full list
Early Q1 2023 data: only 7 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | 5,168 | 5,950,000 | 0.11% |
| UBS Group AG | 439 | 504,538 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 231 | 265,223 | 0.0% |
| MORGAN STANLEY | 168 | 192,943 | 0.0% |
| TWO SIGMA INVESTMENTS, LP | 59 | 68,041 | 0.0% |
| FEDERATED HERMES, INC. | 53 | 60,000 | 0.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 | 34,786 | 0.0% |
| TWO SIGMA ADVISERS, LP | 11 | 12,200 | 0.0% |
| Rockefeller Capital Management L.P. | 0 | 567 | 0.0% |